Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Therapeutic Advances in Gastroenterology
|
June 22, 2019
The 'totality-of-the-evidence' approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference product
Joseph E McClellan, Hugh D Conlon, Michael W Bolt, et al.
Environmental Science & Technology
|
June 28, 2019
Hydrocarbons in Upland Groundwater, Marcellus Shale Region, Northeastern Pennsylvania and Southern New York, U.S.A
Peter B McMahon, Bruce D Lindsey, Matthew D Conlon, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 26, 2019
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Thomas F Lerch, Penelope Sharpe, Stephen J Mayclin, et al.
Toxics
|
January 8, 2025
Predicted Potential for Aquatic Exposure Effects of Per- and Polyfluorinated Alkyl Substances (PFAS) in Pennsylvania's Statewide Network of Streams
Sara E Breitmeyer, Amy M Williams, Matthew D Conlon, et al.
Journal of Veterinary Medical Education
|
November 19, 2019
An Examination of Myers-Briggs Type Indicator Personality, Gender, and Career Interests of Ontario Veterinary College Students
Monika L Goetz, Andria Jones-Bitton, Joanne Hewson, et al.
Journal of Avian Medicine and Surgery
|
December 11, 2007
Pharmacokinetic disposition of the oral iron chelator deferiprone in the white leghorn chicken
Douglas P Whiteside, Ian K Barker, Peter D Conlon, et al.
Journal of Avian Medicine and Surgery
|
December 11, 2007
Pharmacokinetic disposition of the oral iron chelator deferiprone in the domestic pigeon (Columba livia)
Douglas P Whiteside, Ian K Barker, Peter D Conlon, et al.
Journal of Medicinal Chemistry
|
February 14, 1997
Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-diones
M F Braña, J M Castellano, D Perron, et al.
Cancer Research
|
March 1, 1995
Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity
P F Bousquet, M F Braña, D Conlon, et al.
Mabs
|
April 20, 2017
Infliximab crystal structures reveal insights into self-association
Thomas F Lerch, Penelope Sharpe, Stephen J Mayclin, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Therapeutic Advances in Gastroenterology
|
June 22, 2019
The 'totality-of-the-evidence' approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference product
Joseph E McClellan, Hugh D Conlon, Michael W Bolt, et al.
Environmental Science & Technology
|
June 28, 2019
Hydrocarbons in Upland Groundwater, Marcellus Shale Region, Northeastern Pennsylvania and Southern New York, U.S.A
Peter B McMahon, Bruce D Lindsey, Matthew D Conlon, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 26, 2019
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Thomas F Lerch, Penelope Sharpe, Stephen J Mayclin, et al.
Toxics
|
January 8, 2025
Predicted Potential for Aquatic Exposure Effects of Per- and Polyfluorinated Alkyl Substances (PFAS) in Pennsylvania's Statewide Network of Streams
Sara E Breitmeyer, Amy M Williams, Matthew D Conlon, et al.
Journal of Veterinary Medical Education
|
November 19, 2019
An Examination of Myers-Briggs Type Indicator Personality, Gender, and Career Interests of Ontario Veterinary College Students
Monika L Goetz, Andria Jones-Bitton, Joanne Hewson, et al.
Journal of Avian Medicine and Surgery
|
December 11, 2007
Pharmacokinetic disposition of the oral iron chelator deferiprone in the white leghorn chicken
Douglas P Whiteside, Ian K Barker, Peter D Conlon, et al.
Journal of Avian Medicine and Surgery
|
December 11, 2007
Pharmacokinetic disposition of the oral iron chelator deferiprone in the domestic pigeon (Columba livia)
Douglas P Whiteside, Ian K Barker, Peter D Conlon, et al.
Journal of Medicinal Chemistry
|
February 14, 1997
Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-diones
M F Braña, J M Castellano, D Perron, et al.
Cancer Research
|
March 1, 1995
Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity
P F Bousquet, M F Braña, D Conlon, et al.
Mabs
|
April 20, 2017
Infliximab crystal structures reveal insights into self-association
Thomas F Lerch, Penelope Sharpe, Stephen J Mayclin, et al.
Page
of 7